HeartFlow

IPO

Decisive Coronary Care

HeartFlow is a healthcare company in San Francisco, United States, founded in 2011. It has raised $464.6M across 7 rounds, most recently a $98.0M Convertible Note in March 2025.

Employees
501–1000
Founded
2011
Business Model
B2B
Total Funding
$464.6M
Last Round
$98.0M Convertible NoteMar 2025
Rounds
7
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 7 funding rounds and 7 investors for this company. to use credits for reveals, or explore the API.

About

Heartflow is an AI-powered medical technology company empowering clinicians with precision tools to detect, understand, and manage coronary artery disease. Its platform includes FFR CT Analysis, Plaque Analysis, and Roadmap Analysis, enabling personalized cardiac care pathways. Heartflow has treated over 650,000 patients across more than 1,800 institutions with extensive peer-reviewed clinical evidence.

Funding & Exit History

Data from Indexed.vcUpdated
IPOAug 2025
$316.7M

7 more events

  • Convertible2025
  • Series F20234 investors
  • Series E20171 investor

Funding: Seed through Convertible Note. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Backend ×1
  • Cloud/Infrastructure ×1
  • Marketing & SEO ×1
  • Other ×1
  • Productivity & Collaboration ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024
Inizio

Inizio helps health and life sciences clients realize product potential through deep expertise, g...

New York, United States10001+Healthcare
Venture RoundTotal funding$4.4B

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

HeartFlow on Indexed.vc
<a href="https://indexed.vc/companies/heartflow"><img src="https://indexed.vc/api/badge/company/heartflow" alt="HeartFlow on Indexed.vc" width="260" height="76" /></a>